ACTIVE

Z+PHARMA

Financial year 2025 · closed on 31/03/2025
Net result
27 k €
-86.2% YoY
Gross margin
376,6 k €
-42.6% YoY
Equity
521,9 k €
-19.1% YoY
Workforce
4,8 ETP
+4.3% YoY

What does Z+PHARMA do?

Z+PHARMA is a Public limited company incorporated in 1994. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Beveren-Kruibeke-Zwijndrecht. It employs on average 4,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0453.060.967
Incorporation
01/07/1994
Legal form
Public limited company
Registered office
Statiestraat 131
2070 Beveren-Kruibeke-Zwijndrecht · FlandreSee on map
Contributed capital
61 500,00 €
Latest accounts
31/03/2025
Average workforce
4,8 ETP
Joint committees (1)
  • 313
Contacts
3 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 11 financial years

20252024202220212012201120102009200820072006
Income statement
Gross margin376,6 k €655,6 k €465,8 k €433,7 k €208,7 k €215,4 k €149,6 k €194,3 k €242,4 k €336,3 k €328,7 k €
EBITDA127,6 k €373,7 k €231,5 k €246,5 k €127,7 k €127,9 k €84,1 k €79,3 k €115,7 k €228 k €204,9 k €
Operating result79,3 k €299,6 k €156,7 k €166,2 k €81,8 k €91,2 k €46,6 k €51 k €47,7 k €157,9 k €128,6 k €
Net result27 k €195,3 k €65,9 k €78,9 k €55,2 k €38,4 k €19,6 k €41 k €17,7 k €104,3 k €85,5 k €
Balance sheet
Equity521,9 k €645 k €443,5 k €443,5 k €307,6 k €252,5 k €241 k €221,4 k €450,4 k €467,7 k €363,4 k €
Total assets648,4 k €828 k €1,2 M €1,2 M €932,5 k €856,2 k €867 k €1,1 M €679,6 k €753 k €713,9 k €
Cash8,2 k €9,3 k €113,7 k €75,3 k €169,7 k €101,4 k €96,7 k €329,6 k €96,9 k €52,3 k €85,8 k €
Debts126,5 k €183 k €771,4 k €779,8 k €624,9 k €603,8 k €625,9 k €847,4 k €229,2 k €285,3 k €350,5 k €
Other
Workforce4,8 ETP4,6 ETP4,4 ETP3,9 ETP2,3 ETP2,3 ETP2,3 ETP2,8 ETP3,2 ETP2,7 ETP2,6 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/03/2025 · 5 active · 9 ended

Active mandates

Jo Willemyns

Bestuurder · since 31 mai 2023

Active
Jozef Colruyt

Bestuurder · since 31 mai 2023

Active
Kris Castelein

Bestuurder · since 31 mai 2023

Active
Stefaan Vandamme

Bestuurder · since 31 mai 2023

Active
Stefan Goethaert

Bestuurder · since 31 mai 2023

Active

Ended mandates

COSIFARMA

Bestuurder · since 30 juin 2009 · 0898.370.052

Represented by Björn Simons

Ended
COSIFARMA

Director · since 30 juin 2009 · 0898.370.052

Represented by Björn Simons

Ended
COSIFARMA

Manager · since 30 juin 2009 · 0898.370.052

Represented by Karla Colpin

Ended
Cosifarma BV

Bestuurder · since 30 juin 2009

Represented by Karla Colpin

Ended
At this address

Other companies at this address

CompanyCBE no.
APO@WZCActive
0547.950.327
COSIFARMAActive
0898.370.052
Annual accounts

Full financial information

202520242022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/04/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/03/202531/03/202431/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months15 months12 months12 months12 months12 months
Filing date24/09/202529/10/202426/05/202330/05/202205/08/202128/05/2020
General meeting16/09/202530/09/202416/05/202317/05/202218/05/202119/05/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

19 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/03/202516/09/202524/09/2025DutchPDF
Abridged model31/03/202430/09/202429/10/2024DutchPDF
Abridged model31/12/202216/05/202326/05/2023DutchPDF
Abridged model31/12/202117/05/202230/05/2022DutchPDF
Abridged model31/12/202018/05/202105/08/2021DutchPDF
Abridged model31/12/201919/05/202028/05/2020DutchPDF
Abridged model31/12/201821/05/201906/08/2019DutchPDF
Abridged model31/12/201715/05/201826/07/2018DutchPDF
Abridged model31/12/201616/05/201729/08/2017DutchPDF
Abridged model31/12/201517/05/201627/08/2016DutchPDF
Abridged model31/12/201419/05/201527/08/2015DutchPDF
Abridged model31/12/201320/05/201426/08/2014DutchPDF
Abridged model31/12/201221/05/201331/07/2013DutchPDF
Abridged model31/12/201115/05/201224/08/2012DutchPDF
Abridged model31/12/201017/05/201112/08/2011DutchPDF
Abridged model31/12/200918/05/201002/08/2010DutchPDF
Abridged model31/12/200819/05/200903/06/2009DutchPDF
Abridged model31/12/200720/05/200829/05/2008DutchPDF
Abridged model31/12/200615/05/200705/06/2007DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 5 active · 9 ended

Active mandates

Jo Willemyns

Bestuurder · since 31 mai 2023

Active
Jozef Colruyt

Bestuurder · since 31 mai 2023

Active
Kris Castelein

Bestuurder · since 31 mai 2023

Active
Stefaan Vandamme

Bestuurder · since 31 mai 2023

Active
Stefan Goethaert

Bestuurder · since 31 mai 2023

Active

Ended mandates

COSIFARMA

Bestuurder · since 30 juin 2009 · 0898.370.052

Represented by Björn Simons

Ended
COSIFARMA

Director · since 30 juin 2009 · 0898.370.052

Represented by Björn Simons

Ended
COSIFARMA

Manager · since 30 juin 2009 · 0898.370.052

Represented by Karla Colpin

Ended
Cosifarma BV

Bestuurder · since 30 juin 2009

Represented by Karla Colpin

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Capital / shares06/12/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - KAPITAAL - AANDELEN
    PDF
  • Mandates18/11/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other10/05/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Mandates18/08/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/12/2013
    BENAMING - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates21/09/2009
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates29/01/2009
    ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202527 k €
  2. 2024
    Annual accounts 2024195,3 k €
  3. 2022
    Annual accounts 202265,9 k €
  4. 2021
    Annual accounts 202178,9 k €
  5. 2012
    Annual accounts 201255,2 k €
  6. 2011
    Annual accounts 201138,4 k €
  7. 2010
    Annual accounts 201019,6 k €
  8. 2009
    Annual accounts 200941 k €
  9. 2008
    Annual accounts 200817,7 k €
  10. 2007
    Annual accounts 2007104,3 k €
  11. 2006
    Annual accounts 200685,5 k €
  12. 01/07/1994
    IncorporationPublic limited company